Omega Therapeutics

Omega Therapeutics is a privately held, development-stage biotechnology company pioneering a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to transform human medicine.

Industries

Biotechnology

Headquarters

Cambridge, United States

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

Mahesh Karande

President & CEO, Board Director

Collapse

Joshua Reed

CFO

Ling Zeng

Chief Legal & Administrative Officer

Yan Moore

Chief Medical Officer

Thomas McCauley

Chief Scientific Officer

Sivakesava Sakhamuri

SVP, Head of Technical Operations

VP, Data & IT

VP, Biology

VP, Formulations

VP, Head of Computational Genomics & Data Sciences

Teams

View all

Board of Directors

9 members

Leadership Team

6 members

CEO and Executive Team

4 members

Founding Team

1 members

Discover similar companies

Cytodyn

Vancouver, United States · Post IPO Equity

Ultivue

Cambridge, United States · Series D

Adaptive Phage Therapeutics

Gaithersburg, United States · Grant

Regeneron

Tarrytown, United States · Post IPO Equity

Be Bio

Cambridge, United States · Series B

Verve Therapeutics

Cambridge, United States · IPO

Biogen

Cambridge, United States

Century Therapeutics

Philadelphia, United States · Post IPO Equity

Guardant Health

Redwood City, United States · Venture

Genentech

South San Francisco, United States · Venture

Natera

Austin, United States · Post IPO Equity

Biomason

Durham, United States · Series C

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.